Multiplexing	O
Fluorescence	O
Anisotropy	O
Using	O
Frequency	B:C0022885
Encoding	I:C0022885

In	O
this	O
report	O
,	O
a	O
method	O
to	O
multiplex	O
fluorescence	O
anisotropy	O
measurements	O
is	O
described	O
using	O
frequency	B:C0022885
encoding	I:C0022885
.	O

As	O
a	O
demonstration	O
of	O
the	O
method	O
,	O
simultaneous	O
competitive	O
immunoassays	B:C0020980
for	O
insulin	B:C0021641
and	O
glucagon	B:C0017687
were	O
performed	O
by	O
measuring	O
the	O
ratio	O
of	O
bound	B:C1317461
and	O
free	B:C0487017
Cy5	I:C0487017
-	I:C0487017
insulin	I:C0487017
and	O
FITC	B:C0017687
-	I:C0017687
glucagon	I:C0017687
in	O
the	O
presence	O
of	O
their	O
respective	O
antibodies	B:C0003241
.	O

A	O
vertically	O
polarized	O
635	O
nm	O
laser	O
was	O
pulsed	O
at	O
73	O
Hz	O
and	O
used	O
to	O
excite	O
Cy5	B:C0021641
-	I:C0021641
insulin	I:C0021641
,	O
while	O
a	O
vertically	O
polarized	O
488	O
nm	O
laser	O
pulsed	O
at	O
137	O
Hz	O
excited	O
FITC	B:C0017687
-	I:C0017687
glucagon	I:C0017687
.	O

The	O
total	O
emission	O
was	O
split	O
into	O
parallel	O
and	O
perpendicular	O
polarizations	B:C0016316
and	O
collected	O
onto	O
separate	O
photomultiplier	O
tubes	O
.	O

The	O
signals	O
from	O
each	O
channel	B:C0439799
were	O
demodulated	O
using	O
a	O
fast	B:C0002045
Fourier	I:C0002045
transform	I:C0002045
,	O
resolving	O
the	O
contributions	O
from	O
each	O
fluorophore	O
.	O

Anisotropy	O
calculations	B:C0201805
were	O
carried	O
out	O
using	O
the	O
magnitude	O
of	O
the	O
peaks	O
in	O
the	O
frequency	O
domain	B:C0205147
.	O

The	O
method	O
produced	O
the	O
expected	B:C1517001
shape	B:C0332479
of	O
the	O
calibration	O
curves	B:C0205134
with	O
limits	O
of	O
detection	B:C0442726
of	O
0.6	O
and	O
5	O
nM	O
for	O
insulin	B:C0021641
and	O
glucagon	B:C0017687
,	O
respectively	O
.	O

This	O
methodology	O
could	O
readily	O
be	O
expanded	B:C0205229
to	O
other	O
biological	B:C0460002
systems	I:C0460002
and	O
further	B:C1517331
multiplexed	O
to	O
monitor	O
increased	O
numbers	O
of	O
analytes	O
.	O

